Profile: Avalon pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development of potential first-in-class cancer therapeutics. Our AVN944 is a phase I clinical development product for the treatment of hematologic and solid tumor cancers. We also offer preclinical programs to develop inhibitors for the beta-catenin and aurora pathways. We are also engaged in the discovery programs for survivin and myc pathway inhibitors.